Finance

Lists
THYROCARE:NSE
Thyrocare Technologies Ltd
₹552.70
-0.90%
(-5.00) 1D
Sep 11, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for THYROCARE...
Open
₹552.00
High
₹555.95
Low
₹545.00
Mkt. cap
87.97B
Avg. vol.
0.00
Volume
394.90K
Dividend
1.69%
Quarterly dividend
₹2.33
Ex-dividend date
Jun 23, 2026
P/E ratio
50.23
52-wk high
₹662.00
52-wk low
₹342.55
EPS
₹11.00
Shares outstanding
52.76M
No. of employees
2K
Open
₹552.00
High
₹555.95
Low
₹545.00
Mkt. cap
87.97B
Avg. vol.
0.00
Volume
394.90K
Dividend
1.69%
Quarterly dividend
₹2.33
Ex-dividend date
Jun 23, 2026
P/E ratio
50.23
52-wk high
₹662.00
52-wk low
₹342.55
EPS
₹11.00
Shares outstanding
52.76M
No. of employees
2K
Profile
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
About Thyrocare Technologies Ltd
CEO-
Employees1.91K
Founded1996
HeadquartersNavi Mumbai, Maharashtra, India
SectorHealth care provider
Websitethyrocare.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.17B
1.96B
2.24B
2.40B
Cost of goods sold
932.90M
829.60M
1.17B
1.02B
Cost of revenue
932.90M
829.60M
1.17B
1.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
292.50M
-
Operating expense
634.00M
763.70M
460.70M
734.70M
Total operating expenses
1.57B
1.59B
1.63B
1.75B
Operating income
598.40M
362.00M
613.70M
647.80M
Other non operating income
30.50M
50.70M
-112.20M
41.50M
EBT including unusual items
625.80M
353.90M
644.30M
682.90M
EBT excluding unusual items
625.80M
415.50M
525.80M
682.90M
Income tax expense
147.70M
73.40M
157.30M
169.60M
Effective tax rate
23.60%
20.74%
24.41%
24.84%
Other operating expenses
518.90M
547.40M
-126.20M
609.80M
Net income
479.90M
290.10M
471.10M
521.90M
Net profit margin
22.16%
14.84%
21.04%
21.74%
Earnings per share
-
2.11
2.98
3.22
Interest and investment income
-
-
34.00M
-
Interest expense
-5.90M
-
-15.20M
-13.50M
Net interest expenses
-5.90M
-
18.80M
-13.50M
Depreciation and amortization charges
115.10M
216.30M
140.30M
124.90M
EBITDA
713.00M
477.75M
711.78M
745.88M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps